Loading company…
Hangzhou-based Ustar Biotechnologies develops point-of-care molecular diagnostic tests, including nucleic acid testing products.
Ustar Biotechnologies (Hangzhou) Ltd researches and develops point-of-care testing products, focusing on POCT molecular diagnostics and related technologies. Based in Hangzhou, China and established in 2005, its products have covered more than 2,000 medical and health institutions in China and been sold to about 60 countries. The company's technology has received support from the Bill & Melinda Gates Foundation and the World Health Organization, and it is recorded at the Series E stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in